Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.7.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2017
Jun. 30, 2016
Statement of Cash Flows [Abstract]    
NET CASH PROVIDED BY OPERATING ACTIVITIES $ 1,231 $ 1,869
INVESTING ACTIVITIES    
Purchase of medical equipment and property (1,893) (7,187)
Proceeds from sale of medical equipment and property 2,623 1,827
NET CASH PROVIDED BY (USED IN) INVESTING ACTIVITIES 730 (5,360)
FINANCING ACTIVITIES    
Principal payments on revolving credit facility, term loans and capital lease obligations (24,419) (29,190)
Cash proceeds from revolving credit facility 19,105 32,575
Debt issuance costs (28)  
Common stock repurchased to satisfy statutory withholding on employee stock based compensation plans (28) (33)
Cash proceeds from stock plans 87 126
NET CASH (USED IN) PROVIDED BY FINANCING ACTIVITIES (5,283) 3,478
Net change in cash and cash equivalents (3,322) (13)
Cash and cash equivalents, beginning of period 3,398 818
Cash and cash equivalents, end of period $ 76 $ 805